Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | EPRX | NAUT | ||
| Company | Cellectis S.A. ADR | Eupraxia Pharmaceuticals Inc | Nautilus Biotechnology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.81 | 7.38 | 1.9900 | ||
| High | 4.87 | 8.00 | 2.0201 | ||
| Low | 4.67 | 7.25 | 1.9450 | ||
| Latest | 4.75 | 7.55 | 1.9800 | ||
| Change | -0.09 | +0.21 | -0.0200 | ||
| % Change | -1.86% | +2.86% | -1.00% | ||
| Volume | 39,100 | 93,100 | 172,300 | ||
| 20-Day Average Volume | 112,550 | 132,705 | 240,395 | ||
| Previous Close | 4.84 | 7.34 | 2.0000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.67 | 6.38 | 1.9845 | ||
| 20-Day Raw Stochastic | 54.55% | 80.26% | 35.09% | ||
| 20-Day Relative Strength | 54.92 | 68.74 | 55.13 | ||
| Weighted Alpha | +206.62 | +150.15 | +54.79 | ||
| Today's Opinion | 96% Buy | 100% Buy | 80% Buy | ||
| Previous Opinion | 96% Buy | 100% Buy | 96% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.18% since 12/18/25 | +20.80% since 12/18/25 | +2.06% since 12/18/25 | ||
| Low | 4.18 on 12/19/25 | 6.23 on 12/19/25 | 1.8657 on 12/19/25 | ||
| High | 5.03 on 12/24/25 | 8.00 on 12/26/25 | 2.0300 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | -5.75% since 11/26/25 | +21.19% since 11/26/25 | -12.78% since 11/26/25 | ||
| Low | 3.91 on 12/17/25 | 5.72 on 12/02/25 | 1.7800 on 12/17/25 | ||
| High | 5.45 on 12/11/25 | 8.00 on 12/26/25 | 2.3500 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +41.37% since 09/26/25 | +31.53% since 09/26/25 | +138.90% since 09/26/25 | ||
| Low | 2.48 on 09/29/25 | 5.25 on 11/06/25 | 0.7901 on 09/29/25 | ||
| High | 5.48 on 10/16/25 | 8.00 on 12/26/25 | 2.5400 on 11/20/25 | ||
| 6-Month | |||||
| %Chg | +219.26% since 06/26/25 | +63.42% since 06/26/25 | +145.35% since 06/26/25 | ||
| Low | 1.41 on 06/27/25 | 4.67 on 06/27/25 | 0.6200 on 09/04/25 | ||
| High | 5.48 on 10/16/25 | 8.00 on 12/26/25 | 2.5400 on 11/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 264,005 | 271,506 | 250,084 | ||
| Shares Outstanding, K | 55,580 | 35,961 | 126,305 | ||
| Annual Sales | 49,220,000 | 0 | 0 | ||
| Annual Net Income | -36,760,000 | -25,500,000 | -70,780,000 | ||
| Last Quarter Sales | 37,160,000 | 0 | 0 | ||
| Last Quarter Net Income | 590,000 | -6,360,000 | -13,570,000 | ||
| 60-Month Beta | 2.82 | 1.38 | 1.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 11/07/25 | -0.19 on 11/04/25 | -0.11 on 10/27/25 | ||
| Latest Earnings Date | 03/12/26 | 03/19/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||